𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults

✍ Scribed by Zurina Cinza Estévez; Arístides Aguilar Betancourt; Verena Muzio González; Nelvis Figueroa Baile; Carmen Valenzuela Silva; Francisco Hernández Bernal; Eduardo Pentón Arias; Aurora Delhanty Fernández; Nelia Martin Olazábal; Amaurys del Río Martín; Lester Leal Batista; Gloria Véliz Ríos; Héctor Hernández Hernández; Aracelis Blanco Hernández; Evelyn Pérez Lugo; Joel de la Torre Cruz; Bertha L. Batista Marchec; Leovaldo Álvarez Falcón; Jannet Trujillo Brito; Darién Ortega León; Pedro López Saura

Book ID
113491601
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
156 KB
Volume
35
Category
Article
ISSN
1045-1056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Recombinant-yeast-derived hepatitis b va
Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine
✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis